EUR-Lex Search results
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
You are here
Search Results
Case C-179/24 P: Appeal brought on 1 March 2024 by enercity AG against the judgment of the General Court (Fifth Chamber, Extended Composition) delivered on 20 December 2023 in Case T-65/21, enercity AG v European Commission
- CELEX number:
- 62024CN0179
- Form:
- Judicial information
- Author:
- Court of Justice
- Date of document:
- 01/03/2024
Case C-2/24 P: Appeal brought on 4 January 2024 by Teva Pharmaceutical Industries Ltd and Cephalon Inc. against the judgment of the General Court (Third Chamber, Extended Composition) delivered on 18 October 2023 in Case T-74/21, Teva Pharmaceutical Industries and Cephalon v Commission
- CELEX number:
- 62024CN0002
- Form:
- Judicial information
- Author:
- Court of Justice
- Date of document:
- 04/01/2024
Summary of Commission Decision of 21 September 2023 relating to a proceeding under article 101 of the treaty on the functioning of the european union and article 53 of the eea agreement (CASE AT.40760 – HAND GRENADES) (Notified under document number c(2023) 6290 final) – On 21 September 2023, the Commission adopted a Decision relating to a proceeding under Article 101 of the Treaty on the Functioning of the European Union and Article 53 of the EEA Agreement. In accordance with the provisions of Article 30 of Council Regulation (EC) No 1/2003, the Commission herewith publishes the names of the parties and the main content of the decision, including any penalties imposed, having regard to the legitimate interest of undertakings in the protection of their business secrets.
C/2023/6290
- CELEX number:
- 52023AT40760
- Form:
- Summary
- Author:
- European Commission, Directorate-General for Competition
- Date of document:
- 21/09/2023; Date of adoption
Final Report of the Hearing Officer – Case AT.40760 – Hand Grenades
C/2023/6290
- CELEX number:
- 52023AT40760(01)
- Form:
- Report
- Author:
- European Commission, Directorate-General for Competition
- Date of document:
- 18/09/2023; Date of adoption
Opinion of the Advisory Committee on Restrictive Practices and Dominant Positions at its meeting on 18 September 2023 concerning a draft Decision in case COMP AT.40760 – Hand grenades – Meeting by Video Conference – via Skype for Business – Rapporteur: Poland
C/2023/6290
- CELEX number:
- 52023AT40760(02)
- Form:
- Opinion
- Author:
- Advisory Committee on Restrictive Practices and Dominant Positions
- Date of document:
- 18/09/2023; Date of adoption
Case T-74/21: Judgment of the General Court of 18 October 2023 — Teva Pharmaceutical Industries and Cephalon v Commission (Competition — Agreements, decisions and concerted practices — Modafinil market — Decision finding an infringement of Article 101 TFEU — Patent dispute settlement agreement — Restriction of competition by object — Characterisation — Restriction of competition by effect — Conditions for exemption under Article 101(3) TFEU — Fines)
- CELEX number:
- 62021TA0074
- Form:
- Judicial information
- Author:
- General Court
- Date of document:
- 18/10/2023
Case C-147/20: Judgment of the Court (Fifth Chamber) of 17 November 2022 (request for a preliminary ruling from the Landgericht Hamburg — Germany) — Novartis Pharma GmbH v Abacus Medicine A/S (Reference for a preliminary ruling — Intellectual property — EU trade mark — Regulation (EU) 2017/1001 — Article 9(2) — Rights conferred by a mark — Article 15 — Exhaustion of the rights conferred by a trade mark — Parallel import of medicinal products — Repackaging of the product bearing the mark — New outer packaging — Opposition by the proprietor of the mark — Artificial partitioning of the markets between Member States — Medicinal products for human use — Directive 2001/83/EC — Article 47a — Safety features — Replacement — Equivalent features — Delegated Regulation (EU) 2016/161 — Article 3(2) — Anti-tampering device — Unique identifier)
- CELEX number:
- 62020CA0147
- Form:
- Judicial information
- Author:
- Court of Justice
- Date of document:
- 17/11/2022
- Number of pages:
- 2
Joined Cases C-253/20 and C-254/20: Judgment of the Court (Fifth Chamber) of 17 November 2022 (requests for a preliminary ruling from the Hof van beroep te Brussel — Belgium) — Impexeco NV v Novartis AG (C-253/20), PI Pharma NV v Novartis AG, Novartis Pharma NV (C-254/20) (References for a preliminary ruling — Articles 34 and 36 TFEU — Free movement of goods — Intellectual property — Trade marks — Regulation (EC) No 207/2009 — Article 9(2) — Article 13 — Directive 2008/95 — Article 5(1) — Article 7 — Rights conferred by a trade mark — Exhaustion of the rights conferred by a trade mark — Parallel imports of medicinal products — Reference medicinal product and generic medicinal product — Economically linked undertakings — Repackaging of the generic medicinal product — New outer packaging — Affixing the trade mark of the reference medicinal product — Opposition by the proprietor of the trade mark — Artificial partitioning of the markets between the Member States)
- CELEX number:
- 62020CA0253
- Form:
- Judicial information
- Author:
- Court of Justice
- Date of document:
- 17/11/2022
- Number of pages:
- 2
Case C-204/20: Judgment of the Court (Fifth Chamber) of 17 November 2022 (request for a preliminary ruling from the Landgericht Hamburg — Germany) — Bayer Intellectual Property GmbH v kohlpharma GmbH (Reference for a preliminary ruling — Intellectual property — Trade marks — Directive (EU) 2015/2436 — Approximation of the laws of the Member States relating to trade marks — Article 10(2) — Rights conferred by a trade mark — Article 15 — Exhaustion of the rights conferred by a trade mark — Parallel import of medicinal products — Repackaging of the product bearing the mark — New outer packaging — Opposition by the proprietor of the mark — Artificial partitioning of the markets between Member States — Medicinal products for human use — Directive 2001/83/EC — Article 47a — Safety features — Replacement — Equivalent features — Delegated Regulation (EU) 2016/161 — Article 3(2) — Anti-tampering device — Unique identifier)
- CELEX number:
- 62020CA0204
- Form:
- Judicial information
- Author:
- Court of Justice
- Date of document:
- 17/11/2022
- Number of pages:
- 2
Domain: All, EUROVOC descriptor: market-sharing agreement, Search language: English